NCT01969149View on ClinicalTrials.gov

Exenatide for Stress Hyperglycemia

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2016

Conditions

Stress Hyperglycemia

Interventions

DRUG

Exenatide

DRUG

Insulin

Trial Locations (1)

25030

Post operative intensive care unit of the cardiac surgery department, Besançon

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

lead

Centre Hospitalier Universitaire de Besancon

OTHER